Insights from leading experts on real-world clinical adoption of Virtual Humans and strategic leadership
How can Virtual Humans be integrated into clinical workflows to deliver real value for the healthcare industry?
Interview 1: Strategic direction, industry leadership, and ELEM’s vision – Christopher Morton (CEO, ELEM Biotech)
Christopher Morton, CEO of ELEM Biotech, reflects on the outcomes of the Virtual Human Global Summit II and shares his vision for scaling Virtual Human and biomedical simulation technologies. He discusses the growing alignment between industry, research, and regulators, and the strategic role that ELEM plays in advancing computational medicine globally.
💊 “Today, medicine is broadly empirical. Experience is what will give practitioners the possibility to make the best decisions in the fastest possible time.”
Interview 2: Real-world clinical adoption, hospital workflow integration – Antoni Gilabert (Hospital del Mar)
Antoni Gilabert, Director at Hospital del Mar, shares insights on how virtual human technologies can integrate into hospital workflows and support clinical decision-making. He highlights how when professionals, hospitals, and policymakers operate at different speeds, real progress in healthcare is hindered.
💊 “When micro-level reality, meso-level management, and macro-level policy aren’t synchronized, decisions slow down, processes become inefficient, and the impact on patients is delayed. Finally they are starting to move in harmony, creating the conditions for better decisions, better processes, and much better outcomes”.
Thanks also to events like VHGS II, collaboration is accelerating, and the impact is just around the corner.
You have any question related to Virtual Humans?